Abstract
Recent evidence indicates that the p53 tumor suppressor protein, and its related family member, p73, play an essential role in regulating neuronal apoptosis in both the developing and injured, mature nervous system. In the developing nervous system, they do so by regulating naturally-occurring cell death in neural progenitor cells and in postmitotic neurons, acting to ensure the apoptosis of cells that either do not appropriately undergo the progenitor to postmitotic neuron transition, or that fail to compete for sufficient quantities of trophic support. Somewhat surprisingly, in developing postmitotic neurons, p53 plays a proapoptotic role, while a naturally-occurring, truncated form of p73, ΔNp73, antagonizes p53 and plays an anti-apoptotic role. In the mature nervous system, numerous studies indicate that p53 is essential for the neuronal death in response to a variety of insults, including DNA damage, ischemia and excitotoxicity. It is likely that all of these insults culminate in DNA damage, which may well be a common trigger for neuronal apoptosis. In this regard, the signaling pathways that are responsible for triggering p53-dependent neuronal apoptosis are starting to be elucidated, and involve cell cycle deregulation and activation of the JNK pathway. Finally, accumulating evidence indicates that p53 is perturbed in the CNS in a number of neurodegenerative disorders, leading to the hypothesis that longterm oxidative damage and/or excitotoxicity ultimately trigger p53-dependent apoptosis in the chronically degenerating nervous system. Cell Death and Differentiation (2000) 7, 880–888
Similar content being viewed by others
Main
The p53 tumor suppressor gene is the most frequently mutated gene in human tumors. As a tumor suppressor, p53 plays a key role in DNA damage repair, cell cycle regulation, and cellular apoptosis. The mechanisms that underly the ability of p53 to subserve these functions in cycling, nonneuronal cells have been intensively studied and are the subject of several recent reviews.1,2,3 We will not cover these topics in detail here, but will instead focus upon the role of p53 in neurons, a cell type that is ‘forever’ postmitotic, and that must survive and maintain its genome over as long as a century in humans. Moreover, we will discuss emerging evidence that the recently-described p53 family member, p73, also plays a major role in regulating development and survival in the nervous system.
The p53 family and developmental apoptosis in the nervous system
During nervous system development both progenitor cells and postmitotic neurons are overproduced, and the nervous system then chooses, through a process of elimination, those cells that have differentiated and made appropriate connections. It is now clear that the nervous system selects cells during two major periods of apoptosis. The first takes place in the ventricular and subventricular zones of the developing nervous systems, where neural stem and progenitor cells differentiate to produce the neurons and glial cells that will migrate and populate the brain and spinal cord. It is likely that this period of apoptosis serves two functions; to eliminate those progenitors that do not differentiate appropriately, and to ensure that the appropriate cell number is generated in rapidly-growing tissues such as the cerebral cortex. The existence of this period of apoptotic death has only recently been appreciated, and the mechanisms that control the life versus death of any given cell are still only poorly understood.
The second period of apoptotic death in the nervous system occurs once newly-born neurons have migrated to their final destinations, have extended their axons, and have attempted to establish appropriate connections. This period of naturally-occurring neuronal death eliminates approximately half of the neurons in any given population.4 In the peripheral nervous system, where this process has been extensively studied, neurons compete for limiting amounts of target-derived neurotrophins such as nerve growth factor (NGF), and their ultimate survival is dependent upon the interplay between receptor-mediated prosurvival and proapoptotic signals.5 Over the past several years, evidence has emerged implicating the p53 family in both of these periods of developmental apoptosis.
p53 is essential for the elimination of neural progenitor cells that fail to differentiate appropriately
Mice that carry a null mutation in the p53 gene are born and survive until early adulthood, when they succumb to a variety of tumors,6 an observation that initially led to the conclusion that p53 was not involved in development. However, closer examination revealed that a significant portion of p53−/− embryos developed craniofacial abnormalities and died as a consequence of an overproduction of neural tissue and failed neural tube closure (exencephaly),7,8 indicating that p53 was important in regulating neural development.
Additional evidence supporting a role for p53 in progenitor cell development came from studies of mice lacking the retinoblastoma tumor suppressor protein (pRb).9,10,11 The Rb−/− mice die during embryogenesis, and have a striking nervous system phenotype consisting of ectopic mitoses and massive neural apoptosis. Further studies indicated (i) that this phenotype was due to the inability of newly-born neurons to undergo terminal mitosis in the absence of pRb,12,13,14 and (ii) that coincident deletion of p53 rescued the apoptotic phenotype in the Rb−/− CNS.15,16 Thus, inappropriate terminal differentiation in the absence of pRb led to activation of a p53 default apoptotic pathway. The existence of this p53 apoptotic pathway in progenitors suggests that a major role for p53 is to eliminate neural progenitors that fail to differentiate appropriately. A deficit in this pathway in the p53−/− mice would provide at least a partial explanation for their exencephaly.
Insights into other potential players in this progenitor cell apoptotic pathway derive from recent studies of mice carrying null alleles in genes that are part of a death receptor-independent, intrinsic apoptotic pathway.17 This pathway, which can be activated by p5318 independently of its transcriptional function,24 involves release of cytochrome c from the mitochondria, oligomerization and activation of Apaf-1 and caspase 9, and subsequent activation of caspase 3 and other effector caspases.17 Remarkably, animals mutant in each of Apaf1,19,20 caspase 9,21 and caspase 3,22,23 all display a dramatic overgrowth of neural tissue during embryogenesis, as a consequence of decreased progenitor cell apoptosis. Moreover, the Apaf1−/− mice display abnormalities in craniofacial structures,19,20 a phenotype also observed in the p53−/− embryos.8 These data therefore indicate that the intrinsic apoptotic pathway is critical during neural progenitor cell development and suggest that p53 is at least partially responsible for its activation.
An essential role for p53 and p73 during naturally-occurring sympathetic neuron death
A potential role for p53 in the apoptosis of postmitotic neurons was originally suggested by two sets of studies. First, a large number of studies documented increases in p53 following neural injury (reviewed below; Table 1). Second, overexpression of p53 was sufficient to induce the apoptosis of postmitotic sympathetic,25 hippocampal,26 and cortical27 neurons. Since these original reports, a number of studies have been published demonstrating that p53 is necessary for neuronal apoptosis, either following neural injury (reviewed below; Table 1), or during naturally-occurring neuronal death. With regard to the latter, the best-characterized example involves sympathetic neurons of the peripheral nervous system, which we will focus upon here.
During development, peripheral sympathetic neurons become postmitotic, extend their axons to appropriate target tissues, and then about half of these neurons undergo apoptosis during the first 3 postnatal weeks. The survival of any given neuron during this period is determined by its ability to compete for limiting amounts of target-derived nerve growth factor (NGF).5 NGF binds to the neuronal TrkA tyrosine kinase receptor, leading to the activation of a number of survival pathways, the most important of which is the Ras-PI3-kinase-Akt pathway.28,29 This pathway supports sympathetic neuron survival by overriding a receptor-mediated apoptotic signaling cascade that originates from a second neurotrophin receptor, the p75 neurotrophin receptor (p75NTR).28,29 Genetic support for this model derives from the findings that (i) all sympathetic neurons die in the TrkA−/−30 and NGF−/−31 mice, (ii) naturally-occurring sympathetic neuron death is greatly delayed in p75NTR−/− mice,32 and (iii) the coincident deletion of p75NTR rescues the sympathetic neuron death in the TrkA−/− mice (M Majdan and F Miller, unpublished observations). Thus, sympathetic neurons are ‘destined to die’ as a consequence of an ongoing, p75NTR-mediated apoptotic signal, and survive only if they sequester sufficient NGF to robustly activate TrkA.
A number of recent studies indicate that p53 and the related p73 play a key role in regulating the survival of sympathetic neurons during this developmental period. First, overexpression of p53 is sufficient to cause the death of sympathetic neurons in the presence of NGF.25 Second, Vogel and Parada33 demonstrated that embryonic p53−/− sympathetic neurons showed enhanced survival in culture in the absence of NGF, their obligate survival factor. Third, Aloyz et al 34 demonstrated that p53 levels increased when sympathetic neurons underwent apoptosis in response to either NGF withdrawal or activation of p75NTR, and that apoptosis could be inhibited if this increase in p53 levels was prevented. Moreover, developmental sympathetic neuron death was delayed (but not prevented) in the p53−/− mice.34 Thus, p53 is important in an apoptotic signaling cascade that is activated following NGF withdrawal or p75 neurotrophin receptor activation.
What is this apoptotic signaling cascade? Evidence indicates that NGF withdrawal activates at least two apoptotic signaling pathways, both of which may converge onto p53 (Figure 1). One of these pathways, which is also activated by p75NTR, involves JNK-p53-Bax.34,35 MEKK and JNK function upstream of p53 in p75NTR-mediated apoptosis,34 while cdc42/Rac1,36 Ask1,37 MKK, JNK, c-jun,38,39,40 and p5334 have been shown to act in a signaling pathway regulating NGF withdrawal-induced apoptosis. TrkA can silence the JNK-p53 arm of this pathway via Ras activation.29,41 A second pathway shown to be important for NGF withdrawal involves the activation of the cell cycle regulatory molecules CDK4/6, which activate pRb by phosphorylation, and subsequently cause sympathetic neuron apoptosis.42,43 Since pRb dysregulation (i) is known to cause p53 activation via p19ARF in nonneuronal cells,44 and (ii) leads to p53-dependent apoptosis in the embryonic nervous system (reviewed above), then it follows that this cell cycle pathway might also converge onto p53. If this were the case, then p53 would play a pivotal role in integrating neuronal apoptotic stimuli, perhaps thereby ensuring that apoptosis ensues only when these stimuli reach a certain critical threshold (Figure 1).
Surprisingly, the p53 family member p7345,46,47 also plays an essential role in this system, but whereas p53 is proapoptotic, p73 is anti-apoptotic. A recent study by Pozniak et al 48 indicates that the predominant isoform of p73 in the developing brain and sympathetic ganglia is truncated at the amino-terminus (ΔNp73), and lacks the transactivation domain.49 Levels of ΔNp73β are high in sympathetic neurons when they are maintained in NGF, but decrease dramatically when NGF is withdrawn; if this decrease is prevented by ectopic expression of ΔNp73, neurons are rescued from apoptosis. Moreover, in p73−/− mice,49 developmental sympathetic neuron death is enhanced, indicating an essential anti-apoptotic role for p73 in these neurons. How does ΔNp73 inhibit sympathetic neuron apoptosis? ΔNp73 can directly bind to p53, at least in vitro, and can rescue p53-mediated death of sympathetic neurons.48 Thus, one mechanism whereby ΔNp73 might inhibit apoptosis is by binding to p53 and inhibiting its proapoptotic actions (Figure 1).
Does p73 play a similar anti-apoptotic role in other populations of developing or mature neurons? Although this question has not yet been answered, the phenotype of the p73−/− mice indicates that p73 is essential for normal neural development.49 These mice display hippocampal dysgenesis, absence of certain neuronal subtypes in both the central and peripheral nervous systems, and many die showing greatly enlarged ventricles and decreased cortical tissue. Although there are several potential explanations for these phenotypes, they could be explained by the absence of an anti-apoptotic activity in selected populations of CNS neurons and/or progenitors. Moreover, the truncated form of p73β that is predominantly observed in the developing brain48 is generated from the same gene as the full-length, proapoptotic form of p73 by alternative promoter usage,49 providing a mechanism for rapidly altering the ratios of the proapoptotic versus anti-apoptotic isoforms of p73 in the nervous system. In this regard, one potential explanation for the partial penetrance of the neural phenotype observed in the p53−/− embryos is that p73 may be able to compensate for the absence of p53 in the nervous system, at least with regard to developmental apoptosis. p73 may also play a role in differentiation; a recent publication132 indicates that full-length p73 causes differentiation of neuroblastoma cells, a finding that may well have implications for neural development.
p53 and neuronal injury: p53 mediates neuronal apoptosis in response to DNA damage
The apoptotic mechanisms underlying p53-mediated apoptosis in injured neurons are perhaps best-understood in the case of DNA damage. These studies have not only shed light on intracellular mechanisms that become increasingly important in long-lived cells, but have also provided insights into the neuronal apoptosis observed in acute injury and some forms of neurodegeneration. In this regard, we will discuss first the mechanistic insights gained studying DNA damage in neurons, and then the implications that these have for the traumatized nervous system.
A large body of work indicates that almost any DNA-damaging agent can cause the apoptosis of postmitotic neurons, including sympathetic, cortical, hippocampal and cerebellar neurons, and that in all cases this apoptosis is dependent upon p53 (Table 1). Examples include ionizing radiation,80,81,82 cytosine arabinoside (araC),83,84,85,86 DNA topoisomerase II inhibitors such as etoposide,81 cisplatin,87 and the topoisomerase I inhibitor camptothecin.88 Recent studies indicate that this activity is essential for the nervous system; absence of the DNA repair protein XRCC4 led to a massive neural apoptosis, presumably as a consequence of the accumulated DNA damage, and this apoptosis was rescued by coincident deletion of p53.89
How does DNA damage cause the activation and stabilization of p53? This question has perhaps been best answered for camptothecin-induced death of cortical neurons (Figure 2), but similar findings have been reported in other systems. Camptothecin leads to a rapid phosphorylation of pRb and p107,90 and increased levels of p53. This increase is likely to be at least partially mediated via a CDK4/6-pRb-E2F-p53 pathway, since camptothecin-induced apoptosis can be inhibited by dominant-inhibitory CDK4 or 691,92 and dominant-inhibitory DP1,90 a binding partner for E2Fs.93,94 Moreover, both ionizing radiation-induced death of hippocampal neurons26 and camptothecin-induced death of cortical neurons90 can be partially rescued by expression of a pRb mutant lacking phosphorylation sites, including the CDK4/6 site. Once p53 levels are increased, this in turn results in increased Bax levels and caspase activation; these downstream events are eliminated in p53−/− neurons.95 The activation of Bax is essential for apoptosis in response to both ionizing radiation96 and camptothecin.95 However, caspase inhibitors either have no or limited effects, suggesting the possibility of caspase-independent apoptosis downstream of Bax.97,98 That these alterations are essential for p53-mediated apoptosis is further supported by a recent study showing that the apoptosis observed following ectopic overexpression of p53 was abolished in Bax−/− cerebellar granule neurons, and reduced in caspase 3−/− neurons.99
A second potential mechanism for stabilization of p53 in response to DNA damage involves the product of the ataxia telangiectasia mutated (ATM) gene.100 AT is characterized by a spectrum of disorders, including progressive neurodegeneration that is most pronounced in the cerebellum. ATM is required for p53 stabilization in response to DNA damage,101 and can phosphorylate p53.102,103 The importance of this interaction in neurons derives from recent reports by McKinnon and colleagues101,104 who show that ionizing radiation is unable to induce neural apoptosis in ATM−/− mice, a phenotype similar to that seen in p53−/− mice.101 Moreover, the increase in p53 that is observed following ionizing radiation in wild-type mice is absent in ATM−/− mice, leading to the conclusion that ATM is upstream of p53. Interestingly, the Bax−/− mice display a similar resistance to ionizing radiation,104 supporting the existence of an ATM-p53-Bax pathway (Figure 2). The recently-identified checkpoint kinase CHK2 is another potential player in this pathway; like ATM, CHK2 is required for p53 stabilization and apoptosis following ionizing radiation,105 supporting the notion that interactions between all three of these proteins are necessary for an appropriate DNA damage response.106 The point at which the CDK4/6-pRb-E2F1-p53 pathway intersects with the ATM/CHK2-p53 pathway in regulating neuronal apoptosis has not been defined (Figure 2).
Interestingly, the DNA damage-induced apoptosis of neurons can be rescued by growth factors. TGFβ rescues ionizing radiation-induced apoptosis of hippocampal neurons,26 and NGF and BDNF rescue araC and camptothecin-induced apoptosis of sympathetic107 and cortical neurons,108 respectively. In these latter two situations, the rescue is mediated as a consequence of Trk receptor-mediated activation of MEK.
An essential role for p53 in neuronal apoptosis due to excitotoxicity and ischemia
The first indication that p53 might be important for neuronal apoptosis following ischemia or excitotoxicity came from studies showing that p53 levels increased in response to these insults (Table 1). A similar elevation of p53 was observed in response to dopamine-neurotoxicity,79 traumatic brain injury,73 and adrenalectomy,77 the latter of which causes selective apoptosis of hippocampal granule cells (summarized in Table 1). In many of these injury paradigms, p53 is essential for apoptosis (Table 1). Of particular interest are studies demonstrating (i) that kainate was able to induce death of p53+/+ but not p53−/− cortical and hippocampal neurons, even though intracellular calcium was elevated to the same degree in both populations of neurons,50 and (ii) that kainate-induced seizures led to significant apoptosis in p53+/+ but not p53−/− mice.52 These studies definitively established that p53 was an essential downstream component of NMDA receptor-mediated excitotoxicity. Similar studies have confirmed that p53 is also essential for neuronal apoptosis following ischemia,65 adrenalectomy,78 and hypoxia.72
What is the molecular mechanism linking excitotoxin exposure to p53 activation? A number of lines of evidence indicate that it likely involves DNA damage. First, excitotoxicity may be associated with the accumulation of single-strand DNA breaks.109 Second, the alterations downstream of excitotoxicity are similar to those downstream of DNA damage in the same neurons. For example, in cortical neurons, excitotoxicity-induced apoptosis is blocked in Bax−/− neurons,95 as it is in p53−/− neurons,50 and there is little or no inhibition of this apoptosis with caspase inhibitors,97,98 findings very similar to those observed for camptothecin.97,98 One potential difference between these two pathways is upstream of p53; kainate-induced apoptosis is inhibited in JNK3−/− mice,110 but camptothecin-induced neuronal apoptosis is thought to be triggered by a CDK4/6-pRb-E2F-p53 pathway (Figure 2). However, a recent report indicates that DNA damage-induced apoptosis is inhibited in JNK1−/−, JNK2−/− cells,111 suggesting either that there are two pathways to p53 following DNA damage, as there are following growth factor withdrawal (Figure 1), or that these two pathways intersect upstream of p53.
These findings suggest that the formation of DNA strand breaks is a key molecular event linking excitotoxic injury and the induction of apoptosis. How does this occur? Accumulating evidence has invoked a role for oxidative damage in the response to neuronal damage and, potentially in the degeneration of neurons in neurodegenerative diseases (discussed below). In this regard, glutamate receptor activation leads to the generation of reactive oxygen species.112,113 Reactive oxygen species are known to induce DNA strand breaks, and exposure of neurons to reactive oxygen species leads to neuronal apoptosis.114,115,116,117 Enhancement of p53 expression has been observed in numerous cell types following exposure to reactive oxygen species.118 Moreover, p53 is essential for neuronal apoptosis after exposure to stimuli that increase reactive oxygen species, such as ionizing radiation.80,81 Taken together, these data suggest that any form of neuronal injury that produces an excess of free radicals, such as excitotoxic insults, could generate DNA strand breaks, which in turn could provide a signal for stabilizing and activating p53.
Is p53 involved in neurodegeneration?
Together, the aforementioned studies make a strong case that p53 is likely to be involved in the acute neuronal apoptosis that is observed following stroke or traumatic brain injury. However, the evidence implicating p53 in chronic neurodegeneration is largely indirect, and can be summarized as follows. First, p53 is increased in appropriate regions in the brains of individuals suffering from a number of neurodegenerative disorders.119,120,121 For example, p53 is increased in the temporal and frontal lobes of brains from Alzheimer's disease (AD) patients, in the spinal cord of ALS patients, and in the striatum of Parkinsons disease patients.121 Although there is as yet some controversy as to whether this increase is localized to neurons and/or glial cells, it is clear that p53 is elevated. Second, there is accumulating evidence that some neurodegenerative conditions involve oxidative or excitotoxic mechanisms,122,123,124125 both of which would be predicted to cause DNA damage, and to potentially lead to p53-dependent apoptosis. For example, nitric oxide has recently been invoked in the motor neuron apoptosis observed in both familial and sporadic ALS.126 Finally, it is clear that any situation that leads to an increase in the DNA mutation load in neurons is likely to lead to neuronal death. In this regard, cancer chemotheraphy with agents such as cisplatin87 might trigger both short-term and long-term p53-dependent neuronal apoptosis. Alternatively, mutations that interfere with the repair system itself would be predicted to increase the mutation load, and potentially lead to a chronic and progressive neurodegeneration. The best example of this is the neurodegenerative disorder AT;100 it is likely that the inability to repair DNA using the ATM/p53 system ultimately causes neurodegeneration in a p53-independent fashion. In support of this idea, a recent study indicates that there is chronic and progressive neurodegeneration in the p53−/− mice.127 Although this finding may seem counterintuitive, it is likely that the inability to properly scan and repair DNA in the absence of p53 would ultimately lead to a nonfunctional neuron that would die by a p53-independent mechanism.
Of the few experimental studies exploring the role of p53 in neurodegeneration, most are focused upon AD. In one study, Xu et al 128 demonstrated that transfection of wild-type amyloid precursor protein (APP) into neuroblastoma cells was sufficient to rescue them from apoptosis induced by UV irradiation or by p53 itself. However, a mutant form of APP found in familial Alzheimer's had no effect, leading to the hypothesis that APP protects neurons from apoptosis by controlling p53 and that mutations in APP could enhance neuronal vulnerability to p53-mediated apoptosis. In a second study, LaFerla et al 129 examined a transgenic mouse expressing beta-amyloid protein (Abeta) in neurons, and found a correlation between Abeta accumulation in neurons, activation of p53 and DNA fragmentation. Both of these studies would predict that the elevated p53 found in AD cortex might be important in the neurodegeneration. Arguing against this conclusion are two studies reporting that Abeta-mediated apoptosis did not require p53.130,131
Together, these studies highlight the difficulties of ascertaining the involvement of a given signaling pathway in human neurodegeneration. Nonetheless, the accumulating evidence that oxidative stress and excitotoxicity lead to p53-dependent apoptosis, and that perturbations in DNA repair can also lead to longterm neuronal degeneration, provide a strong argument for pursuing the potential involvement of p53 in a set of debilitating degenerative diseases for which we currently have no treatment.
Abbreviations
- Abeta:
-
beta-amyloid protein
- APP:
-
amyloid precursor protein
- AraC:
-
cytosine arabinoside
- ATM:
-
ataxia telangiectasia mutated
- BDNF:
-
brain-derived neurotrophic factor
- CNS:
-
central nervous system
- NGF:
-
nerve growth factor
- pRb:
-
retinoblastoma protein
- p75NTR:
-
p75 neurotrophin receptor
References
Bates S and Vousden KH . 1999 Mechanisms of p53-mediated apoptosis. Cell Mol. Life Sci. 55: 28–37
Choisy-Rossi C and Yonish-Rouach E . 1998 Apoptosis and the cell cycle: the p53 connection. Cell Death Differ. 5: 129–131
Ko LJ and Prives C . 1996 p53: puzzle and paradigm. Genes Dev. 10: 1054–1072
Oppenheim RW . 1991 Cell death during development of the nervous system. Annu. Rev. Neurosci. 14: 453–501
Majdan M and Miller FD . 1999 Neuronal life and death decisions: functional antagonism between the Trk and p75 neurotrophin receptors. Int. J. Dev. Neurosci. 17: 153–161
Donehower LA, Harvey M, Slagle BL, McArthur MJ and Montgomery CA . 1992 Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215–221
Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT and Jacks T . 1995 A subset of p53-deficient embryos exhibit exencephaly. Nature Genet. 10: 175–179
Armstrong JF, Kaufman MH, Harrison DJ and Clarke AR . 1995 High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol. 5: 931–936
Clarke AR, Maandag ER, Vam Roon M, Van der Lugt NMT, Van der Valk M, Hooper MI, Berns A and Te Reile H . 1992 Requirement for a functional Rb-1 gene in murine development. Nature 359: 328–330
Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA and Weinberg RA . 1992 Effects of an Rb mutation in the mouse. Nature 359: 295–300
Lee EHP, Chang CY, Hu N, Wang YCJ, Lai CC, Herrup K, Lee WH and Bradley A . 1992 Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288–294
Lee E, Hu N, Yuan SSF, Cox LA, Bradley A, Lee W and Herrup K . 1994 Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes Dev. 8: 2008–2021
Slack RS, El-Bizri H, Wong J, Belliveau DJ and Miller FD . 1998 A critical temporal requirement for the pRb family during neuronal determination. J. Cell Biol. 140: 1497–1509
Tsai KY, Hu U, Macleod KF, Crowley D, Yamasaki L and Jacks T . 1998 Mutation of E2F-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell. 2: 293–304
Morgenbesser SD, Jacks T and DePinho RA . 1994 p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72–74
MacLeod KF, Hu Y and Jacks T . 1996 Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15: 6178–6188
Green DR and Reed JC . 1998 Mitochondria and apoptosis. Science 281: 1309–1312
Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW and Lowe SW . 1999 Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284: 156–159
Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM and Mak TW . 1998 Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94: 739–750
Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA and Gruss P . 1998 Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94: 727–737
Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P and Flavell RA . 1998 Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94: 325–337
Kuida K, Zheng TS, Na S, Kuan C-Y, Yang D, Karasuyama H, Rakic HP and Flavell RA . 1996 Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368–372
Roth KA, Kuan C, Haydar TF, D'Sa-Eipper C, Shindler KS, Zheng TS, Kuida K, Flavell RA and Rakic P . 2000 Epistatic and independent functions of caspase-3 and Bxl-X(L) in developmental programmed cell death. Proc. Natl. Acad. Sci. USA 97: 466–471
Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P and Green DR . 2000 p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J. Biol. Chem. 275: 7337–7342
Slack RS, Belliveau DJ, Rosenberg M, Atwal J, Lochmuller H, Aloyz R, Haghighi A, Lach B, Seth P, Cooper E and Miller FD . 1996 Adenovirus-mediated gene transfer of the tumor suppressor, p53, induces apoptosis in postmitotic neurons. J. Cell Biol. 135: 1085–1096
Jordan J, Galindo MF, Prehn JHM, Weichselbaum RR, Beckett M, Ghadge GD, Roos RP, Leiden JM and Miller RJ . 1997 p53 expression induces apoptosis in hippocampal pyramidal neuron cultures. J. Neurosci. 17: 1397–1405
Xiang H, Hochman DW, Saya H, Fujiwara T, Schwartzkroin PA and Morrison RS . 1996 Evidence for p53-mediated modulation of neuronal viability. J. Neurosci. 16: 6753–6765
Kaplan DR and Miller FD . 1997 Signal transduction by the neurotrophin receptors. Curr. Opin. Cell. Biol. 9: 213–221
Kaplan DR and Miller FD . 2000 Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10: 381–391
Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA and Barbacid M . 1994 Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368: 246–248
Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP, Ling LH, McMahon SB, Shelton DL, Levinson AD and Phillips HS . 1994 Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76: 1001–1011
Bamji SX, Majdan M, Pozniak CD, Belliveau DJ, Aloyz R, Kohn J, Causing GG and Miller FD . 1998 The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally-occurring sympathetic neuron death. J. Cell. Biol. 140: 911–923
Vogel KS and Parada LF . 1998 Sympathetic neuron survival and proliferation are prolonged by loss of p53 and neurofibromin. Mol. Cell. Neurosci. 11: 19–28
Aloyz RS, Bamji SX, Pozniak CD, Toma JG, Atwal J, Kaplan DR and Miller FD . 1998 p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J. Cell. Biol. 143: 1691–1703
Deckwerth TL, Elliott JL, Knudson CM, Johnson Jr EM, Snider WD and Korsmeyer SJ . 1996 BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 17: 401–411
Bazenet CE, Mota MA and Rubin LL . 1998 The small GTP-binding protein Cdc42 is required for nerve growth factor withdrawal-induced neuronal death. Proc. Natl. Acad. Sci. USA 95: 3984–3989
Kanamoto T, Mota M, Takeda K, Rubin LL, Miyazono K, Ichijo H and Bazenet CE . 2000 Role of apoptosis signal-regulating kinase in regulation of the c-Jun n-terminal kinase pathway and apoptosis in sympathetic neurons. Mol. Cell. Biol. 20: 196–204
Estus S, Zaks WJ, Freeman RS, Gruda M, Bravo R and Johnson Jr EM . 1994 Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell. Biol. 127: 1717–1727
Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M and Rubin LL . 1995 A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14: 927–939
Eilers A, Whitfield J, Babij C, Rubin LL and Ham J . 1998 Role of the jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. J. Neurosci. 18: 1713–1724
Mazzoni IE, Said FA, Aloyz R, Miller FD and Kaplan DR . 1999 Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway. J. Neurosci. 19: 9716–9727
Park DS, Farinelli SE and Greene LA . 1996 Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J. Biol. Chem. 271: 8161–8170
Park DS, Levine B, Ferrari G and Greene LA . 1997 Cyclin dependent kinase inhibitor and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J. Neurosci. 17: 8975–8983
Sherr CJ and Weber JD . 2000 The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10: 94–99
Kaghad M, Bonnet H, Yang A, Creacier L, Biscan JC, Valent A, Minty A, Chalon P, Lellas JM, Dumont X, Ferrara P, McKeon F and Caput D . 1997 Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809–819
Jost CA, Marin MC and Kaelin Jr WG . 1997 p73 is a human p53 related protein that can induce apoptosis. Nature 389: 191–194
Levrero M, De Laurenzi V, Costanzo A, Gong J, Melino G and Wang JYJ . 1999 Structure, function and regulation of p63 and p73. Cell Death Differ. 6: 1146–1153
Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR and Miller FD . 2000 An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 289: 304–306
Yang A, Walker N, Bronson R, Kaghad M, Oosterwegal M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F and Caput D . 2000 p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumors. Nature 404: 99–103
Xiang H, Hochman DW, Saya H, Fujiwara T, Schwartzkroin PA and Morrison RS . 1996 Evidence for p53-mediated modulation of neuronal viability. J. Neurosci. 16: 6753–6765
Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA and Schwartzkroin PA . 1996 Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J. Neurosci. 16: 1337–1345
Sakhi S, Bruce A, Sun N, Tocco G, Baudry M and Schreiber SS . 1994 p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. USA 91: 7525–7529
Sakhi S, Sun N, Wing LL, Mehta P and Schreiber SS . 1996 Nuclear accumulation of p53 protein following kainic acid-induced seizures. NeuroReport 7: 493–496
Liu W, Rong Y, Baudry M and Schreiber SS . 1999 Status epilepticus induces p53 sequence-specific DNA binding in mature rat brain. Brain Res. Mol. Brain Res. 63: 248–253
Sakhi S, Bruce A, Sun N, Tocco G, Baudry M and Schreiber SS . 1997 Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment. Exp. Neurol. 145: 81–88
Liu X and Zhu XZ . 1999 Roles of p53, c-myc, Bcl-2, Bax and caspases in glutamate-induced neuronal apoptosis and the possible neuroprotective mechanism of basic fibroblast growth factor. Brain Res. Mol. Brain Res. 71: 210–216
Uberti D, Belloni M, Grilli M, Spano P and Memo M . 1998 Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids. Eur. J. Neurosci. 10: 246–254
Hughes PE, Alexi T, Yoshida T, Schreiber SS and Knusel B . 1996 Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation. Neuroscience 74: 1143–1160
Van Lookeren Campagne M and Gill R . 1998 Increased expression of cyclin G1 and p21WAF1/CIP1 in neurons following transient forebrain ischemia: comparison with early DNA damage. J. Neurosci. Res. 53: 279–296
Tomasevic G, Kamme F, Stubberod P, Wieloch M and Wieloch T . 1999 The tumor suppressor p53 and its response gene p21WAF1/Cip1 are not markers of neuronal death following transient global cerebral ischemia. Neuroscience 90: 781–792
McGahan L, Hakim AM and Robertson GS . 1998 Hippocampal myc and p53 expression following transient global ischemia. Brain Res. Mol. Brain Res. 56: 133–145
Tomasevic G, Shamloo M, Israeli D and Wieloch T . 1999 Activation of p53 and its target genes p21 (WAF1/Cip1) and PAG608/Wig-1 in ischemic preconditioning. Brain Res. Mol. Brain Res. 70: 304–313
Joo CK, Choi JS, Ko HW, Park KY, Sohn S, Chun MH, Oh YJ and Gwag BJ . 1999 Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53. Invest. Ophthalmol. Vis. Sci. 40: 713–720
Li Y, Chopp M, Zhang ZG, Zaloga C, Niewenhuis L and Gautam S . 1994 p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke 25: 849–855
Crumrine RC, Thomas AL and Morgan PF . 1994 Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J. Cereb. Blood Flow Metab. 14: 887–891
Li Y, Chopp M and Powers C . 1997 Granule cell apoptosis and protein expression in hippocampal dentate gyrus after forebrain ischemia in the rat. J. Neurol. Sci. 150: 93–102
Li Y, Chopp M, Powers C and Jiang N . 1997 Apoptosis and protein expression after focal cerebral ischemia in rats. Brain Res. 765: 301–312
Watanabe H, Ohta S, Kumon Y, Sakaki S and Sakanaka M . 1999 Increase in p53 protein expression following cortical infarction in the spontaneously hypertensive rat. Brain Res. 837: 38–45
Gillardon F, Spranger M, Tiesler C and Hossmann KA . 1999 Expression of cell death-associated phospho-c-Jun and p53-activated gene 608 in hippocampal CA1 neurons following global ischemia. Brain Res. Mol. Brain Res. 73: 138–143
Banasiak KF and Haddad GG . 1998 Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res. 797: 295–304
Napieralski JA, Raghupathi R and McIntosh TK . 1999 The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury. Brain Res. Mol. Brain Res. 71: 78–86
Kaya SS, Mahmood A, Li Y, Yavuz E, Goksel M and Chopp M . 1999 Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain. Brain Res. 818: 23–33
Manev H, Kharlamov A and Armstrong DM . 1994 Photochemical brain injury in rats triggers DNA fragmentation, p53 and HSP72. Neuroreport 5: 2661–2664
Schreiber SS, Sakhi S, Dugich-Djordjevic MM and Nichols NR . 1994 Tumor suppressor p53 induction and DNA damage in hippocampal granule cells after adrenalectomy. Exp. Neurol. 130: 368–376
Sakhi S, Gilmore W, Tran ND and Schreiber SS . 1996 p53-deficient mice are protected against adrenalectomy-induced apoptosis. Neuroreport 8: 233–235
Daily D, Barzilai A, Offen D, Kamsler A, Melamed E and Ziv I . 1999 The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53. Cell. Mol. Neurobiol. 19: 261–276
Wood KA and Youle RJ . 1995 The role of free radicals and p53 in neuron apoptosis in vivo. J. Neurosci. 15: 5851–5857
Enokido Y, Araki T, Tanaka K, Aizawa S and Hatanaka H . 1996 Involvement of p53 in DNA strand break-induced apoptosis in postmitotic CNS neurons. Eur. J. Neurosci. 8: 1812–1821
Johnson MD, Xiang H, London S, Kinoshita Y, Knudson M, Mayberg M, Korsmeyer SJ and Morrison RS . 1998 Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons. J. Neurosci. Res. 54: 721–733
Winkelman HD and Hines JD . 1983 Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study. Ann. Neurol. 14: 520–527
Martin DP, Wallace TL and Johnson Jr EM . 1990 Cytosine arabinoside kills postmitotic neurons in a fashion resembling trophic factor deprivation: evidence that a deoxycytidine-dependent process may be required for nerve growth factor signal transduction. J. Neurosci. 10: 184–193
Wallace TL and Johnson Jr EM . 1989 Cytosine arabinoside kills postmitotic neurons: evidence that deoxycytidine may have a role in neuronal survival that is independent of DNA synthesis. J. Neurosci. 9: 115–124
Tomkins CE, Edwards SN and Tolkovsky AM . 1994 Apoptosis is induced in post-mitotic rat sympathetic neurons by arabinosides and topoisomerase II inhibitors in the presence of NGF. J. Cell. Sci. 107: 1499–1507
Windebank AJ . 1999 Chemotherapeutic neuropathy. Curr. Opin. Neurol. 12: 565–571
Morris EJ and Geller HM . 1996 Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity. J. Cell Biol. 134: 757–770
Gao Y, Ferguson DO, Xie W, Manis JP, Sekiguchi J, Frank KM, Chaudhuri J, Horner J, DePinho RA and Alt FW . 2000 Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404: 897–900
Park DS, Morris EJ, Bremmer R, Keramaris E, Padmanabhan J, Rosenbaum M, Shelanski ML, Geller HM and Greene LA . 2000 Involvement of retinoblastoma family members and E2F/EP complexes in the death of neurons evoked by DNA damage. J. Neurosci. 20: 3104–3114
Park DS, Morris EJ, Greene LA and Geller HM . 1997 G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J. Neurosci. 17: 1256–1270
Park DS, Morris EJ, Padmanabhan J, Shelanski ML, Geller HM and Greene LA . 1998 Cyclin dependent kinases participate in death of neurons evoked by DNA damaging agents. J. Cell Biol. 143: 457–467
Girling R, Partridge JF, Bandara N, Totty NF, Hsuan JJ and La Thangue NB . 1993 A new component of the transcription factor DRTF1/E2F. Nature 362: 83–87
La Thangue NB . 1994 DTRF1/E2F: an extended family of heterodimeric factors implicated in cell cycle controls. Trends Biochem. Sci. 19: 108–114
Xiang H, Kinoshita Y, Knudson CM, Korsmeyer SJ, Schwartzkroin PA and Morrison RS . 1998 Bax involvement in p53-mediated neuronal cell death. J. Neurosci. 18: 1363–1373
Johnson MD, Xiang H, London S, Kinoshita Y, Knudson M, Mayberg M, Korsmeyer SJ and Morrison RS . 1998 Evidence for involvement of BAX and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons. J. Neurosci. Res. 54: 721–733
Stefanis L, Park DS, Friedman WJ and Greene LA . 1999 Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons. J. Neurosci. 19: 6235–6247
Johnson MD, Kinoshita Y, Xiang H, Ghatan S and Morrison RS . 1999 Contribution of p53-dependent caspase activation to neuronal cell death declines with neuronal maturation. J. Neurosci. 19: 2996–3006
Cregan SP, MacLaurin JG, Craig CG, Robertson GS, Nicholson DW, Park DS and Slack RS . 1999 Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. J. Neurosci. 19: 7860–7869
Shiloh Y . 1997 Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet. 31: 635–662
Herzog KH, Chong MJ, Kapsetaki M, Morgan JI and McKinnon PJ . 1998 Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280: 1089–1091
Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB and Siliciano JD . 1998 Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677–1679
Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NL, Prives C, Reiss Y, Shiloh Y and Ziv Y . 1998 Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674–1677
Chong MJ, Murray MR, Gosink EC, Russell HR, Srinivasan A, Kapsetaki M, Korsmeyer SJ and McKinnon PJ . 2000 Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system. Proc. Natl. Acad. Sci. USA 97: 889–894
Hirao A, Kong Y-Y, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ and Mak TW . 2000 DNA damage-induced activation of p53 by the checkpoint kinase Chk2 (2000). Science 287: 1824–1827
Carr AM . 2000 Piecing together the p53 puzzle. Science 287: 1765–1766
Anderson CNG and Tolkovsky AM . 1999 A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. J. Neurosci. 19: 664–673
Hetman M, Kanning K, Cavanaugh JE and Xia Z . 1999 Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274: 22569–22580
Didier M, Bursztajn S, Adamec E, Passani L, Nixon RA, Coyle JT, Wei JY and Berman SA . 1996 DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. J. Neurosci. 16: 2238–2250
Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P and Flavell RA . 1997 Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389: 865–870
Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA and Davis RJ . 2000 Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870–874
Bondy SC and Lee DK . 1993 Oxidative stress induced by glutamate receptor agonists. Brain Res. 610: 229–233
Lafon-Cazal M, Culcasi M, Gaven F, Pietri S and Bockaert J . 1993 Nitric oxide, superoxide and peroxynitrite: putative mediators of NMDA-induced cell death in cerebellar granule cell. Neuropharmacology 32: 1259–1266
Enokido Y and Hatanaka H . 1993 Apoptotic cell death occurs in hippocampal neurons cultured in a high oxygen atmosphere. Neuroscience 57: 965–972
Whittemore ER, Loo DT and Cotman CW . 1994 Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. Neuroreport 5: 1485–1488
Yamada M, Enokido Y, Ikeuchi T and Hatanaka H . 1995 Epidermal growth factor prevents oxygen-triggered apoptosis and induces sustained signalling in cultured rat cerebral cortical neurons. Eur. J. Neurosci. 7: 2130–2138
Ciriolo MR, De Martino A, Lafavia E, Rossi L, Carri MT and Rotilio G . 2000 Cu,Zn-superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells. J. Biol. Chem. 275: 5065–5072
Y J, Wang S, Leonard SS, Sun Y, Butterworth L, Antonin J, Ding M, Rojanasakul Y, Vallyathan V, Castranova V and Shi X . 1999 Role of reactive oxygen species and p53 in chromium (VI)-induced apoptosis. J. Biol. Chem. 274: 34974–34980
Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y and Taniguchi T . 1997 Changes of p53 in the brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 232: 418–421
De la Monte SM, Sohn YK and Wands JR . 1997 Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J. Neurol. Sci. 152: 73–83
De la Monte SM, Sohn YK, Ganju N and Wands JR . 1998 p53- and CD95-associated apoptosis in neurodegenerative diseases. Lab. Invest. 78: 401–411
Beal MF . 1996 Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6: 661–666
Shaw PJ and Ince PG . 1997 Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J. Neurol. 244: 3–14.
Grunewald T and Beal MF . 1999 Bioenergetics in Huntington's disease. Ann. N.Y. Acad. Sci., 893: 203–213
Markesbery WR . 1997 Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23: 134–147
Estevez AG, Crow JP, Sampson JB, Reiter C, Zhuang Y, Richardson GJ, Tarpey MM, Barbeito L and Beckman JS . 1999 Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286: 2498–2500
Amson R, Lassalle JM, Halley H, Prieur S, Lethrosne F, Roperch JP, Israeli D, Gendron MC, Duyckaerts C, Checler F, Dausset J, Cohen D, Oren M and Telerman A . 2000 Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice. Proc. Natl. Acad. Sci. USA 97: 5346–5350
Xu X, Yang D, Wyss-Coray T, Yan J, Gan L, Sun Y and Mucke L . 1999 Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 96: 7547–7552
LaFerla FM, Hall CK, Ngo L and Jay G . 1996 Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. J. Clin. Invest. 98: 1626–1632
Blasko I, Wagner M, Whitaker N, Grubeck-Loebenstein B and Jansen-Durr P . 2000 The amyloid beta peptide abeta (25-35) induces apoptosis independent of p53. FEBS Lett. 470: 221–225
Giovanni A, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, Robertson GS, Slack RS and Park DS . 2000 E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3 (2000). J. Biol. Chem. 275: 11553–11560
De Laurenzi V, Raschella G, Barcaroli D, Annicchiarico-Petruzzelli M, Ranalli M, Catani MV, Tanno B, Costanzo A, Levrero M and Melino G . 2000 Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J. Biol. Chem. 275: 15226–15231
Acknowledgements
We would like to thank David Kaplan for reading the manuscript and providing advice.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by G Melino
Rights and permissions
About this article
Cite this article
Miller, F., Pozniak, C. & Walsh, G. Neuronal life and death: an essential role for the p53 family. Cell Death Differ 7, 880–888 (2000). https://doi.org/10.1038/sj.cdd.4400736
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400736
Keywords
This article is cited by
-
Tumor suppressor p53 modulates activity-dependent synapse strengthening, autism-like behavior and hippocampus-dependent learning
Molecular Psychiatry (2023)
-
A Promising Drug Candidate as Potent Therapeutic Approach for Neuroinflammation and Its In Silico Justification of Chalcone Congeners: a Comprehensive Review
Molecular Neurobiology (2023)
-
Restraint Stress Exacerbates Apoptosis in a 6-OHDA Animal Model of Parkinson Disease
Neurotoxicity Research (2023)
-
MDMX elevation by a novel Mdmx–p53 interaction inhibitor mitigates neuronal damage after ischemic stroke
Scientific Reports (2022)
-
Dose-Dependent Effects of Astaxanthin on Ischemia/Reperfusion Induced Brain Injury in MCAO Model Rat
Neurochemical Research (2022)